Pascal is a co-founder and Chief Scientific Officer at Polyneuron. He is responsible for the company’s research & development activities as well as regulatory affairs. Since the company foundation Pascal was instrumental in delivering on key company milestones in preclinical drug development, the management of contract research activities, and the interaction with health authorities. He holds a . in Pharmaceutical Sciences from the University of Basel and completed his . at the University of Zürich in Molecular Medicine. During this time he specialized on hematological diseases. Importantly, he then laid the scientific foundation for a promising novel treatment of a hematological orphan disorder and was also involved in the setup of a clinical trial.
Fermenta Biotech Ltd (FBL) , incepted under the auspices of Duphar Interfran Ltd (now known as DIL Ltd.), is the brainchild of late Mr. Vasant Kumar Datla. Established in 1986, FBL pioneered the manufacture of Penicillin G Amidase enzyme in India; it emerged as the leader in enzyme technologies for beta lactams (β-lactams) synthesis.
FBL manufactures Vitamin D3 (Cholecalciferol) (the only manufacturer and supplier in India and among the top few manufacturers in the world) and constantly looks for value addition. FBL manufactures Cholecalciferol also know as Vitamin D3 for further applications in global pharmaceutical, food, veterinary and feed industries (premix); cholecalciferol solutions for use in human food supplements; Vitamin D3 resin in oil and Vitamin D3 500 feed grade for use in animal feed supplements; and activated dimethicone powder (Silicon Powder) for antiflatulent use.